Antibe Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$25,055,000 over the previous period. Total operating expenses were $25,529,000.
Profit Margin
| 2012 | 0 | -942.13K | |
|---|---|---|---|
| 2015 | 0 | -4.40M | |
| 2016 | 4.43M | -2.63M | -59.3% |
| 2018 | 8.51M | -7.42M | -87.31% |
| 2019 | 9.53M | -12.81M | -134.36% |
| 2021 | 9.71M | -26.30M | -270.78% |
| 2022 | 0 | -25.05M |
ATE.TO Income Statement (2012 – 2021)
| 2021 | 2020 | 2018 | 2017 | 2015 | 2014 | 2012 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 9.71M | 9.53M | 8.51M | 4.43M | 0 | 0 |
Cost of revenue | 99K | 6.16M | 5.98M | 5.13M | 2.38M | 0 | 0 |
Gross profit | -99K | 3.55M | 3.54M | 3.37M | 2.05M | 0 | 0 |
Operating exp. | |||||||
Research and development | 14.35M | 13.42M | 3.94M | 2.74M | 407.21K | 2.30M | 214.13K |
Selling and marketing | 208K | 2.71M | 3.52M | 3.38M | 202.27K | 53.27K | 0 |
Total operating expenses | 25.52M | 27.81M | 15.73M | 10.03M | 5.23M | 4.42M | 942.13K |
Operating income | -25.52M | -24.71M | -12.18M | -6.66M | -3.28M | -4.42M | -942.13K |
Other income (expenses), net | 279K | -1.20M | -95.06K | -1.04M | -214.50K | 19.57K | 0 |
Income before tax | -25.25M | -24.73M | -12.68M | -7.70M | -3.49M | -4.40M | -942.13K |
Income tax expense | -195K | 1.80M | 134.12K | -274.76K | -865.20K | 0 | 0 |
Net income | -25.05M | -26.30M | -12.81M | -7.42M | -2.63M | -4.40M | -942.13K |
Earnings per share | |||||||
Basic EPS | -0.49 | -0.71 | -0.6 | -0.49 | -0.42 | -1.19 | -0.36 |
Diluted EPS | -0.49 | -0.71 | -0.6 | -0.49 | -0.42 | -1.19 | -0.36 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |